Protagenic Therapeutics, Inc. (PTIXW)

Market Cap	2.32M
Revenue (ttm)	n/a
Net Income (ttm)	-5.24M
Shares Out	588.96K
EPS (ttm)	-13.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,875
Open	0.1240
Previous Close	0.1240
Day's Range	0.1027 - 0.1508
52-Week Range	0.0010 - 0.4900
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2025

About PTIXW

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company’s lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Barrett Evans
• Employees: 3
• Stock Exchange: NASDAQ
• Ticker Symbol: PTIXW
• Website: https://www.protagenic.com